PT2077729E - Formas orais probióticas - Google Patents

Formas orais probióticas Download PDF

Info

Publication number
PT2077729E
PT2077729E PT78390291T PT07839029T PT2077729E PT 2077729 E PT2077729 E PT 2077729E PT 78390291 T PT78390291 T PT 78390291T PT 07839029 T PT07839029 T PT 07839029T PT 2077729 E PT2077729 E PT 2077729E
Authority
PT
Portugal
Prior art keywords
dosage forms
oral dosage
probiotic oral
probiotic
forms
Prior art date
Application number
PT78390291T
Other languages
English (en)
Inventor
Frank E Hodal
Karl P Weinrich
Original Assignee
Le Calumet Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Le Calumet Holdings Llc filed Critical Le Calumet Holdings Llc
Publication of PT2077729E publication Critical patent/PT2077729E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/37—Sugar alcohols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Confectionery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT78390291T 2006-09-27 2007-09-27 Formas orais probióticas PT2077729E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/528,893 US9084434B2 (en) 2006-09-27 2006-09-27 Probiotic oral dosage forms

Publications (1)

Publication Number Publication Date
PT2077729E true PT2077729E (pt) 2014-07-28

Family

ID=38984310

Family Applications (1)

Application Number Title Priority Date Filing Date
PT78390291T PT2077729E (pt) 2006-09-27 2007-09-27 Formas orais probióticas

Country Status (12)

Country Link
US (2) US9084434B2 (pt)
EP (1) EP2077729B1 (pt)
JP (1) JP5224606B2 (pt)
CN (1) CN101541194B (pt)
AU (1) AU2007300461B2 (pt)
CA (1) CA2664583C (pt)
DK (1) DK2077729T3 (pt)
ES (1) ES2500166T3 (pt)
NZ (1) NZ576078A (pt)
PL (1) PL2077729T3 (pt)
PT (1) PT2077729E (pt)
WO (1) WO2008039531A1 (pt)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE529093T1 (de) * 2007-05-10 2011-11-15 Oreal Kosmetische zusammensetzung mit einem inulinderivat in form einer volumsexpandierten emulsion
US9636196B2 (en) 2008-06-13 2017-05-02 ProBiora Health, LLC Use of hydrogen peroxide-producing bacteria for tooth whitening
US20110027420A1 (en) * 2009-07-31 2011-02-03 Haile Mehansho Moisture migration reduction layer for a food product
JP5606835B2 (ja) * 2009-09-01 2014-10-15 大東化学株式会社 食品添加用被覆製剤及びその製造方法
WO2012009503A1 (en) * 2010-07-14 2012-01-19 Vertex Pharmaceuticals Incorporated Palatable pharmaceutical composition comprising vx-950
WO2012031186A1 (en) 2010-09-03 2012-03-08 Wisconsin Pharmacal Company, Llc. Prebiotic suppositories
CN103550258B (zh) * 2010-12-08 2015-08-05 益擎生技股份有限公司 乳酸菌株调节免疫反应的用途
PT2481299T (pt) * 2011-01-31 2017-03-08 Synformulas Gmbh Estirpes de bifidobacterium bifidum para aplicação em doenças gastrointestinais
EP2532354A1 (de) * 2011-06-08 2012-12-12 OrganoBalance GmbH Sprühgetrocknete Lactobacillus Stämme / Zellen und deren Verwendung gegen Helicobacter Pylori
EA028340B1 (ru) * 2011-06-08 2017-11-30 Новозимс А/С Лечение и профилактика инфекций, вызываемых helicobacter pylori у людей и животных, с помощью композиции, содержащей высушенные распылением клетки лактобактерий
CN102204679B (zh) * 2011-06-16 2013-01-30 内蒙古普泽生物制品有限责任公司 一种四联菌片及其制备方法
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
EP2753344A4 (en) 2011-09-09 2015-04-15 Fédération Des Producteurs Acéricoles Du Québec NUTRIENT PROTECTIVE DIET
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
MX2015005165A (es) * 2012-10-25 2015-10-29 Gervais Danone Sa Cepas de streptococcus thermophilus para tratar infeccion por helicobacter pylori.
CN103169140B (zh) * 2012-12-27 2015-03-11 北京中天神舟航天食品技术研究院 指示益生菌活度的可食用微胶囊及其制备方法和应用
ITMI20130476A1 (it) * 2013-03-28 2014-09-29 Novintethical Pharma Sagl Composizioni per il trattamento di disturbi gastro-intestinali a base di complessi di tannini con proteine
US9403181B2 (en) * 2013-07-26 2016-08-02 Paul O'Malley Oral care product formulation
US9554973B2 (en) 2013-07-26 2017-01-31 Paul O'Malley Micro-encapsulation of ozonated oils
CN103859164A (zh) * 2014-02-27 2014-06-18 扬州绿保生物科技有限公司 一种饲料添加剂的生产方法
CN103798392B (zh) * 2014-03-07 2015-12-30 内蒙古伊利实业集团股份有限公司 具有缓解咽喉部炎症功效的益生菌食品组合物及食品
CN103876145B (zh) * 2014-04-01 2016-06-01 吉林大学 一种益生菌微生态片剂及其制备方法
CN103876151A (zh) * 2014-04-09 2014-06-25 吉林大学 一种益生菌微生态胶囊剂及其制备方法
CN107205423A (zh) * 2014-06-12 2017-09-26 加优有限责任公司 向口香糖和其他可食用基底施加调味剂的方法
CN104082744A (zh) * 2014-07-09 2014-10-08 任发政 一种益生菌分散片及其制备方法
US9688967B2 (en) 2014-12-05 2017-06-27 Synlogic, Inc. Bacteria engineered to treat diseases associated with hyperammonemia
TWI788111B (zh) * 2015-01-02 2022-12-21 美商梅拉洛伊卡公司 多元補充品組成物
CN107567333A (zh) * 2015-03-09 2018-01-09 生物免疫Sagl公司 包含抗氧化剂与双歧杆菌和从益生菌分离的细胞壁的抗衰老组合物
SG10202003100XA (en) 2015-05-13 2020-05-28 Synlogic Operating Co Inc Bacteria Engineered to Reduce Hyperphenylalaninemia
EP3294757B1 (en) 2015-05-13 2023-12-27 Synlogic Operating Company, Inc. Bacteria engineered to treat a disease or disorder
WO2016210373A2 (en) 2015-06-24 2016-12-29 Synlogic, Inc. Recombinant bacteria engineered for biosafety, pharmaceutical compositions, and methods of use thereof
ITUB20152151A1 (it) * 2015-07-14 2017-01-14 Ergon Srl Compressa ad elevata concentrazione di fermenti lattici
WO2017040719A1 (en) 2015-08-31 2017-03-09 Synlogic, Inc. Bacteria engineered to treat disorders in which oxalate is detrimental
CN106822007B (zh) * 2015-09-11 2021-12-31 西姆莱斯股份公司 口服制剂
CA3002965A1 (en) 2015-10-30 2017-05-04 Synlogic, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
WO2017075485A1 (en) 2015-10-30 2017-05-04 Synlogic, Inc. Bacteria engineered to treat disorders in which trimethylamine (tma) is detrimental
WO2017087580A1 (en) 2015-11-16 2017-05-26 Synlogic, Inc. Bacteria engineered to reduce hyperphenylalaninemia
WO2017123592A1 (en) 2016-01-11 2017-07-20 Synlogic, Inc. Bacteria engineered to treat disorders associated with bile salts
WO2017123610A2 (en) 2016-01-11 2017-07-20 Synlogic, Inc. Bacteria engineered to detoxify deleterious molecules
EP3405041B1 (en) * 2016-01-19 2021-05-26 Synergia Life Sciences Pvt. Ltd A liquid probiotic composition stable at ambient temperature
US9855305B2 (en) * 2016-03-29 2018-01-02 Companion Therapeutics Llc Pharmaceutical composition containing combinations of vitamins, minerals, probiotics, and prebiotics effective in preventing adverse effects associated with the use of proton-pump inhibitors
US11090342B2 (en) * 2016-04-11 2021-08-17 President And Fellows Of Harvard College Probiotic formulations for improving athletic performance
FI3442547T3 (fi) 2016-04-15 2023-09-05 Baylor College Medicine Lactobacillus reuteri MM4-1A käytettäväksi autismikirjon häiriöiden hoidossa tai ehkäisyssä
US11478516B2 (en) * 2016-08-01 2022-10-25 Rhode Island Hospital Probiotic bacteria-directed prevention or treatment of fungal infection
CN106306284A (zh) * 2016-08-30 2017-01-11 四川高福记生物科技有限公司 一种清除辣火锅痛点的乳酸菌压片糖果及其制备方法
KR20180046692A (ko) * 2016-10-28 2018-05-09 롯데제과 주식회사 과민성 대장증후군 개선용 조성물
KR102004204B1 (ko) * 2016-12-16 2019-07-26 (주)휴온스 안정성이 증진된 유산균 및 이의 제조방법
WO2018111024A1 (ko) * 2016-12-16 2018-06-21 (주)휴온스 안정성이 증진된 유산균 및 이의 제조방법
WO2018111023A1 (ko) * 2016-12-16 2018-06-21 (주)휴온스 안정성이 증진된 유산균 및 이의 제조방법
EP3599899A1 (en) 2017-03-23 2020-02-05 Virun, Inc. Stable dry powders and emulsions containing probiotics and mucoadhesive protein
US10610541B2 (en) * 2017-03-31 2020-04-07 Vantage Specialties, Inc. Prebiotics
GB201708932D0 (en) * 2017-06-05 2017-07-19 Probi Ab Microbial compositions
CA3066085A1 (en) 2017-06-21 2018-12-27 Synlogic Operating Company, Inc. Bacteria for the treatment of disorders
CN107307083A (zh) * 2017-07-25 2017-11-03 石家庄以岭药业股份有限公司 一种燕麦味牛奶益生菌伴侣及其制备方法
WO2019021191A1 (en) 2017-07-26 2019-01-31 Tgx Soft Chew, Llc STARCH-FREE MOUTH PRODUCT FOR VETERINARY APPLICATIONS
CN107752031A (zh) * 2017-10-26 2018-03-06 无限极（中国）有限公司 一种具有调节肠道菌群和保护胃粘膜功能的粉剂及其制备方法与应用
CN107752039A (zh) * 2017-11-21 2018-03-06 常州市阿曼特化工有限公司 一种益生菌菌剂的制备方法
WO2019113023A1 (en) * 2017-12-04 2019-06-13 The BioCollective, LLC Probiotics and methods of use
CN108113003A (zh) * 2017-12-15 2018-06-05 浙江康诺邦健康产品有限公司 一种适合婴幼儿的益生菌软胶囊及其制备方法
CN108004189B (zh) * 2018-01-18 2021-07-27 北京科拓恒通生物技术股份有限公司 一种复合益生乳酸菌粉剂及其制备方法与应用
US11045507B2 (en) 2019-02-21 2021-06-29 Ewelina Sosnowska-Turek Bifidobacterium animalis AMT30 strain and the composition containing the strain of Bifidobacterium animalis AMT30
JP2022530503A (ja) 2019-04-29 2022-06-29 シンロジック オペレーティング カンパニー インコーポレイテッド 遺伝子操作された微生物
CN110384240A (zh) * 2019-08-01 2019-10-29 上海宣泰生物科技有限公司 降血糖的维生素和益生菌发酵物粉营养组合物及其应用
CA3151145A1 (en) 2019-09-24 2021-04-01 David N. Cook Compositions and methods for treatment of inflammatory and immune diseases
CN111280449B (zh) * 2020-02-11 2022-11-11 浙江华康药业股份有限公司 一种肠内缓释糖醇添加剂及其制备方法和应用
IL295353A (en) 2020-03-20 2022-10-01 Synlogic Operating Co Inc Genetically engineered microorganisms to reduce hyperphenylalaninemia
CN111567809A (zh) * 2020-05-26 2020-08-25 奥克斯路株式会社 具有提高免疫力和调节肠道功能的动物双歧杆菌bz11复合菌剂
CN111671090A (zh) * 2020-05-26 2020-09-18 颜如玉医药科技有限公司 一种益生菌组合物及其制剂
EP4256039A2 (en) 2020-12-02 2023-10-11 Synlogic Operating Company, Inc. Engineered microorganisms
WO2022146718A1 (en) 2020-12-31 2022-07-07 Synlogic Operating Company, Inc. Microorganisms engineered to reduce hyperphenylalaninemia
WO2022155201A1 (en) 2021-01-12 2022-07-21 Prolacta Bioscience, Inc. Synbiotic treatment regimens
US20240191176A1 (en) 2021-04-13 2024-06-13 Synlogic Operating Company, Inc. Bacteria engineered to secrete active proteins
BE1029673B1 (nl) * 2021-08-13 2023-03-13 Zinkh Nv Probiotische samenstelling voor verbeterde orale gezondheid
WO2023044479A1 (en) 2021-09-17 2023-03-23 Synlogic Operating Company, Inc. Methods for reducing hyperphenylalaninemia
CN114601019A (zh) * 2022-03-30 2022-06-10 广州瑞铂茵健康科技有限公司 胎盘水溶性提取物作为壁材制备益生菌微胶囊的应用
WO2023245171A1 (en) 2022-06-17 2023-12-21 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases associated with bile acid metabolism and methods of use thereof
WO2023245168A1 (en) 2022-06-17 2023-12-21 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases associated with bile acid metabolism and methods of use thereof
WO2023250478A1 (en) 2022-06-23 2023-12-28 Synlogic Operating Company, Inc. Recombinant bacteria engineered to treat diseases associated with methionine metabolism and methods of use thereof
WO2024081768A1 (en) 2022-10-12 2024-04-18 Synlogic Operating Company, Inc. Bacteria engineered to produce active epidermal growth factor (egf) and their medical uses
WO2024086557A1 (en) 2022-10-17 2024-04-25 Synlogic Operating Company, Inc. Recombinant bacteria expressing phenylalanine ammonia lyase, phenylalanine transporter and l- aminoacid deaminase for reducing hyperphenylalaninemia
WO2024129974A1 (en) 2022-12-14 2024-06-20 Synlogic Operating Company, Inc. Recombinant bacteria for use in the treatment of disorders in which oxalate is detrimental
WO2024130119A2 (en) 2022-12-16 2024-06-20 Prolacta Bioscience, Inc. Synbiotic compositions for short chain fatty acid production

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1427100A (fr) 1964-12-14 1966-02-04 Ile De Rech Pharma Et Therapeu Procédé pour l'obtention d'hydroxyflavanne-3-4-diols
US4518696A (en) 1983-01-11 1985-05-21 Chr. Hansen's Laboratory, Inc. Stabilized liquid bacterial suspension for oral administration to animals
JPS6023321A (ja) 1983-07-19 1985-02-05 Hohnen Oil Co Ltd 長期保存に耐えるビフイズス菌製剤の製造法
US4698360B1 (en) 1985-04-09 1997-11-04 D Investigations Pharmacologiq Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
JPS62207286A (ja) * 1986-03-07 1987-09-11 Meiji Seika Kaisha Ltd ビフイズス菌増殖促進物およびその製造法
JPS63227507A (ja) 1987-03-17 1988-09-21 Ibaraki Pref Gov フザリウム生菌製剤
JPH05255097A (ja) 1992-01-24 1993-10-05 Miyarisan Seibutsu Igaku Kenkyusho:Kk 液状組成物
UA39965C2 (uk) 1993-12-03 2001-07-16 Лайфор Леборетріз Лтд Вірусоцидний, бактерицидний та руйнуючий сперматозоїди вагінальний засіб і вагінальний супозиторій ( варіанти )
US5733568A (en) 1993-12-03 1998-03-31 Lafor Laboratories Limited Micro-encapsulated lactobacilli for medical applications
KR100530508B1 (ko) 1997-01-09 2005-11-23 모리나가 뉴교 가부시키가이샤 락토페린 정제
ATE214597T1 (de) 1997-12-19 2002-04-15 Merck Patent Gmbh Mehrschichttablette enthaltend probiotische mikroorganismen wie z.b. lactobacilli oder bifidobakterien
JP3942716B2 (ja) 1998-01-20 2007-07-11 森永乳業株式会社 アロエ錠剤
US6706287B2 (en) 2001-05-15 2004-03-16 Kibow Biotech Inc. Prebiotic and probiotic compositions and methods for their use in gut-based therapies
JP2001089397A (ja) 1999-09-17 2001-04-03 Morinaga Milk Ind Co Ltd 生理活性物質含有錠剤及びその製造方法
JP3478773B2 (ja) 1999-12-21 2003-12-15 日東薬品工業株式会社 生菌組成物
EP1151673A3 (en) * 2000-05-03 2002-01-02 Societe Des Produits Nestle S.A. Confectionery product having a filling
FI20001402A (fi) 2000-06-13 2001-12-14 Yves Delatte Menetelmä maitohappobakteeritablettien valmistamiseksi ja pakkaamiseksi
CA2416120A1 (en) 2000-07-17 2002-01-24 Svend Laulund Methods and formulations with probiotic microorganisms and medicaments
JP3399919B2 (ja) 2000-09-26 2003-04-28 株式会社ヤクルト本社 発酵乳食品
US7214370B2 (en) 2000-12-18 2007-05-08 Probiohealth, Llc Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
US20040197277A1 (en) 2001-08-24 2004-10-07 The Procter & Gamble Company Chewable compositions with probiotic agents
US7208186B2 (en) 2001-09-18 2007-04-24 Spi Pharma, Inc. Chewing gum formulation and method of making the same
US7118765B2 (en) 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
WO2003080023A2 (en) * 2002-03-20 2003-10-02 Elan Pharma International Limited Fast dissolving dosage forms having reduced friability
KR101095712B1 (ko) 2003-08-21 2011-12-20 오츠카 세이야쿠 가부시키가이샤 점막 면역 부활 작용을 갖는 유산균
WO2005032591A1 (en) 2003-09-30 2005-04-14 Kibow Biotech, Inc. Compositions and methods for augmenting kidney function
WO2005060937A1 (en) 2003-12-23 2005-07-07 Chr. Hansen A/S Compressed tablets comprising viable probiotic microorganisms
GB0330009D0 (en) 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations
DE102004026706A1 (de) 2004-05-28 2005-12-15 Merck Patent Gmbh Orale Darreichungsform enthaltend probiotische Bakterien
US20060093592A1 (en) 2004-10-04 2006-05-04 Nutracea Synbiotics
SE529185C2 (sv) 2005-10-07 2007-05-22 Arla Foods Amba Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt
CN102479952B (zh) 2010-11-23 2014-10-08 清华大学 锂离子电池电极复合材料及其制备方法以及电池

Also Published As

Publication number Publication date
JP2010504981A (ja) 2010-02-18
US9549984B2 (en) 2017-01-24
US9084434B2 (en) 2015-07-21
AU2007300461A2 (en) 2009-06-11
CA2664583A1 (en) 2008-04-03
NZ576078A (en) 2011-06-30
CN101541194B (zh) 2013-09-25
DK2077729T3 (da) 2014-07-28
JP5224606B2 (ja) 2013-07-03
AU2007300461A1 (en) 2008-04-03
EP2077729B1 (en) 2014-04-23
CA2664583C (en) 2014-12-02
US20090117056A1 (en) 2009-05-07
PL2077729T3 (pl) 2014-11-28
US20150359894A1 (en) 2015-12-17
EP2077729A1 (en) 2009-07-15
ES2500166T3 (es) 2014-09-30
AU2007300461B2 (en) 2013-09-26
WO2008039531A1 (en) 2008-04-03
CN101541194A (zh) 2009-09-23

Similar Documents

Publication Publication Date Title
PL2077729T3 (pl) Doustne postacie dawkowania probiotyku
IL206159A0 (en) Oral pharmaceutical dosage forms
SI2399579T1 (sl) Farmacevtske odmerne oblike
PL1935395T3 (pl) Doustna kompozycja
IL199191A0 (en) Modified release ibuprofen solid oral dosage form
IL205160A0 (en) Oral dosage forms comprising licarbazepine acetate
EP2011482A4 (en) SOLID PREPARATION FOR ORAL APPLICATION
HUE033011T2 (hu) Takrolimuszt tartalmazó napi egyszeri orális dózisforma
HK1154484A1 (en) Oral dosage composition
GB0710439D0 (en) Oral dosage form
HK1129566A1 (en) Oral preparation comprising pioglitazone
IL194366A0 (en) Solid dosage formulations
IL184787A0 (en) Oral dosage form comprising rosiglitazone
IL184790A0 (en) Oral dosage form comprising rosiglitazone
HK1206267A1 (en) Stabilized picoplatin oral dosage form
IL198760A0 (en) Oral formulations
GB0616794D0 (en) Solid dosage form
GB0822124D0 (en) Oral dosage form
EP2156842A4 (en) ORAL COMPOSITION
ZA200810854B (en) Oral hygiene
HK1115054A1 (en) Preparation for oral administration
GB0616860D0 (en) Mouth Snagger
GB0704123D0 (en) Dosage form